Skip to main content
. 2020 Apr 20;98(5):751–760. doi: 10.1007/s00109-020-01907-w

Fig. 6.

Fig. 6

Signaling lipid mediators as mid-late-staging indicators. A panel of oxylipins (a) and lysophospholipids (bf) significantly increased from stage II to stage III. The intensity represents the relative quantitation of each metabolite